Boehringer Ingelheim and HealthPrize Technologies today announced the expansion of the RespiPoints digital support program to anyone taking one of several Boehringer Ingelheim medicines, including select medicines available in the Respimat inhaler.
The two companies extend their collaboration to integrate West’s drug delivery systems with HealthPrize’s digital adherence and engagement platform.
We’re packing our bags – and our booth shwag – and getting ready for the Spring season of life science marketing conferences. If you’d like to learn more about HealthPrize, we’d like to learn more about your challenges and goals.
Medication non-adherence is one of the most serious problems in healthcare, posing a heavy financial impact on all constituencies.
Former inVentiv executive brings key pharmaceutical services sector experience to HealthPrize’s board.
The ZS Associates principal will bring her expansive patient engagement and multi-channel marketing experience to HealthPrize’s board
Cost has been one of pharma’s key adherence tactics. But what would happen if we gave away medications for free?
Campaigns to patients and healthcare providers alike are carefully designed to increase the number of prescriptions being written for our medications. But what happens after that first prescription?
Tom Kottler, CEO and cofounder of HealthPrize Technologies, the leading customer motivation management platform for the life sciences, was selected as a 2017 Top 40 Healthcare Transformer by Medical Marketing & Media magazine. Kottler will be recognized, along with fellow honorees, at MM&M’s Transforming Healthcare Conference in New York City.
Watch this video from HealthPrize Technologies and get a look behind the scenes into one family’s (not so) serious conversation about adherence.